As a global leading Contract Development and Manufacturing Organization (CDMO) for Cell and Gene therapy products, Minaris Regenerative Medicine has been offering our clients high value clinical and commercial manufacturing services, development solutions, and technologies for more than 20 years.
Throughout 2022, our team of experts will be attending various industry events.
Meet us at the upcoming CAR-TCR Summit (September 19-23) in Boston, Massachusetts!
What are the benefits of utilizing 3D bioreactors in your allogeneic therapy product?
Our experts have established efficient large-scale cell product processes using 3D bioreactors to expand adherent and non-adherent cells, allowing our team to design service packages and tailor-made solutions for your specific manufacturing needs.
Through the execution of more than 70 successful technology transfers, serving clinical manufacturing programs for over 180 clients, and experience with commercial manufacturing, our knowledge and expertise is unparalleled.
Learn more about how we may be a valuable partner to your therapeutic program.
At Minaris, we are experts for development, clinical, and commercial manufacturing of cell and gene therapies. Together with our partners, we have a vision of creating future cell therapy miracles. This allows us to constantly push the boundaries of medicine to serve patients in need. Watch our video to learn more about how we achieve this.
.png)